Hepatitis C Virus and Cardiovascular Disease
Authors:
- 25 May 2018
- journal article
- editorial
- Published by Japanese Circulation Society in Circulation Journal
- Vol. 82 (6) , 1503-1504
Abstract
Japan's largest platform for academic e-journals: J-STAGE is a full text database for reviewed academic papers published by Japanese societiesKeywords
This publication has 13 references indexed in Scilit:
- Facts and fictions of HCV and comorbidities: Steatosis, diabetes mellitus, and cardiovascular diseasesJournal of Hepatology, 2014
- Cardiac dysfunction associated with a nucleotide polymerase inhibitor for treatment of hepatitis CHepatology, 2014
- Predictive Factors for Response to Peginterferon-Alpha and Ribavirin Treatment of Chronic HCV Infection in Patients Aged 65 Years and MoreDigestive Diseases and Sciences, 2010
- Hepatitis C Infection is Associated With Increased Coronary Artery Atherosclerosis Defined by Modified Reardon Severity Score SystemCirculation Journal, 2008
- Hepatitis C Virus Infection and the Development of Type 2 Diabetes in a Community-based Longitudinal StudyAmerican Journal of Epidemiology, 2007
- Myocarditis and Heart Failure Associated With Hepatitis C Virus InfectionJournal of Cardiac Failure, 2006
- Hepatitis C Virus and the LungChest, 2005
- Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus InfectionNew England Journal of Medicine, 2002
- Significant pulmonary toxicity associated with interferon and ribavirin therapy for hepatitis CAmerican Journal of Gastroenterology, 2002
- Adverse Effects of Interferon on the Cardiovascular System in Patients with Chronic Hepatitis C.Japanese Heart Journal, 1996